Filing Details
- Accession Number:
- 0001093557-20-000109
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-25 18:10:53
- Reporting Period:
- 2020-03-13
- Accepted Time:
- 2020-03-25 18:10:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1093557 | Dexcom Inc | DXCM | Surgical & Medical Instruments & Apparatus (3841) | 330857544 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1466545 | Richard Doubleday | 6340 Sequence Drive San Diego CA 92121 | Evp Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-03-13 | 523 | $0.00 | 51,482 | No | 4 | G | Direct | |
| Common Stock | Disposition | 2020-03-23 | 231 | $207.71 | 10,483 | No | 4 | S | Indirect | by Trust |
| Common Stock | Disposition | 2020-03-23 | 1,300 | $209.55 | 9,183 | No | 4 | S | Indirect | by Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Direct | |
| No | 4 | S | Indirect | by Trust |
| No | 4 | S | Indirect | by Trust |
Footnotes
- The transaction represents a gift by the Reporting Person of 523 shares to a charitable donor advised fund.
- Included in this number are 35,492 unvested restricted stock units, 11,748 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 10,910 of which were granted on March 8, 2019 and shall vest through March 8, 2022 and 12,834 of which were granted on March 8, 2018 and shall vest through March 8, 2021.
- On June 3, 2019, Mr. Doubleday adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Doubleday. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- This transaction was executed in multiple trades at prices ranging from $207.28 to $208.12. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- Shares are held by the Doubleday Living Trust U/A/D 5/26/2015, with respect to which the reporting person is a trustee.
Billionaire Hedge Funds
